Key facts
- Prenatal and early life exposure to PFAS mixtures is linked to higher levels of intestinal inflammation in children.
- This is the first study to examine the impact of PFAS on children during a critical developmental phase.
New research suggests prenatal and early life exposure to PFAS chemicals is linked to higher levels of intestinal inflammation in children. The study, the first of its kind focusing on this critical developmental phase, found a correlation between elevated PFAS levels around birth and inflammation markers up to age 11.
This research highlights a critical early-life pathway to inflammatory bowel diseases, emphasizing the need for policy interventions to protect vulnerable populations from persistent environmental chemicals.
New research indicates a probable link between exposure to 'forever chemicals,' known as PFAS, during prenatal and early life stages and increased intestinal inflammation in children. This first-of-its-kind study, published in a peer-reviewed journal, tracked mother-child pairs from pregnancy or shortly after birth up to age 11. Findings revealed a significant correlation between higher PFAS levels detected around birth and markers of inflammation in the children.
PFAS are a large group of chemicals notorious for their persistence in the environment and association with severe health issues, including cancer, liver problems, and immune disorders. While previous research has connected PFAS to intestinal inflammation in adults, this study specifically highlights the vulnerability of children during critical developmental periods. Researchers analyzed blood samples from mothers, umbilical cords, and newborns, identifying numerous PFAS metabolites and focusing on the most prevalent ones, including PFOA and PFOS.
The study also examined mixtures of these chemicals, reflecting real-world exposure scenarios rather than isolated compounds. Intestinal inflammation was assessed by measuring fecal calprotectin, a biomarker commonly used for monitoring conditions like irritable bowel syndrome. Although the study is the largest of its kind on early-life PFAS exposure and intestinal inflammation, the authors acknowledge the limitation of a small sample size.
Recommendations for mothers include using water filtration systems, opting for organic foods, and avoiding stain guards. The researchers emphasized that their findings underscore the importance of policy development to protect mothers and children from these toxic substances, offering a clearer understanding of the early-life pathways that can lead to inflammatory bowel diseases.